In high risk surgical patients, haemodynamic monitoring is recommended to maintain suitable organ perfusion. 1 Cardiac output is a key cardiovascular parameter and a major determinant of tissue oxygenation. 2 Continuous measurement is preferable to intermittent measurement, especially in the operating theatre when rapid changes in cardiovascular function are often observed. Alternative minimally invasive methods for continuously monitoring cardiac output have then been developed. Two continuous monitors are more frequently used: 1) the oesophageal Doppler method (DCO), and 2) the pulse pressure contour method (PPCO). DCO is accurate in the operating theatre; 3 however, this technique has limitations, including its inability to monitor a continuous signal during surgical haemostasis as a result of electrical interference and lack of access to the mouth in oral surgery and neurosurgery. PPCO is minimally invasive and not operator dependent. A method of calculating stroke volume from the contour of the arterial pressure curve was first described in 1899. 4 PPCO is based on the hypothesis that the waveform of blood pressure is directly related to the variation in the stroke volume. Many algorithms have been proposed: some make a comparison with a closed hydraulic or electric circuit, such as the Windkessel concept, and others analyse the area under the systolic portion of the arterial pressure waveform. Algorithm validity has been verified in a variety of patients and circumstances, but performance could be compromised in the presence of haemodynamic instability, cardiac arrhythmias, or other factors that disturb the arterial pressure waveform, particularly during vasopressor use. 5 6 To increase the reliability of PPCO, some commercial systems have calibrated their algorithms using thermodilution. 5 A prototype for continuously monitoring cardiac output was recently introduced (CombiQ w , Deltex Medical, Chichester, Sussex, UK) that combines oesophageal Doppler and PPCO and includes 9 algorithms to estimate cardiac output after calibration using the DCO value according to a study by Sun and colleagues. 7 The present study compared, in patients under general anaesthesia, the agreement of cardiac output measurements obtained using 9 non-commercial algorithms of PPCO with measures of cardiac output obtained using DCO alone used as a reference. We also analysed variations in cardiac output during haemodynamic challenges, including volume expansion or administration of a vasopressor bolus.
Materials and methods
This prospective, non-interventional, non-randomized study was conducted in neurosurgical patients under general anaesthesia, between November 2011 and July 2012, in the Department of Anaesthesiology at Lariboisière University Hospital (Paris, France). This study was approved by the institutional ethics committee (Comité d'éthique de la Société de Réanima-tion de Langue Française No. 11-356). All subjects gave written informed consent. Haemodynamic monitoring, including invasive blood pressure and DCO, represented the usual care of patients undergoing neurosurgery with reduced cerebral compliance and/or potential bleeding in our institution. The exclusion criteria were age ,18 yrs, pregnancy, contraindication to the use of DCO and chronic cardiac arrhythmia.
Study protocol
All subjects were orally premedicated with hydroxyzine (1 mg kg 21 ) 1 h before surgery. Anaesthesia was induced with propofol and remifentanil target controlled infusion. Tracheal intubation was facilitated with a atracurium 0. 
Haemodynamic management
Mean arterial pressure (MAP), measured the day before the surgical intervention, was considered to be the MAP of reference (MAPref). According to our standard of care, a decrease in MAP.20% of MAPref led to a therapeutic intervention according to the choice of the physician in charge: including a fluid challenge (250 ml of saline in 10 min) or a bolus of vasopressor. Three different vasopressors were available according to the choice of the physician (bolus of 50 mcg of phenylephrine, 5 mcg of norepinephrine or 9 mg of ephedrine).
Data collection
After zeroing the system to atmospheric pressure, the arterial pressure waveform was carefully checked using a fast flush test to ensure optimal harmonics of the arterial pressure measurement system. The arterial pressure signal was transferred from the bedside monitor to the DCO system using a serial cable. Nine nonproprietary PPCO algorithms built into the CardioQ-Combi software provide continuous cardiac output values. The 9 PPCO algorithms are described in Table 1 and in the Supplementary material. Haemodynamic data were automatically recorded by the monitor every 5 s. Initial calibration of the PPCO was performed using the DCO value before any intervention and after stabilizing heart rate and arterial pressure (,5% variation over a 1-min period). Each therapeutic event was automatically recorded on the monitor using two predefined categories: fluid challenge or vasopressor bolus. The peak effect of the therapeutic action was recorded 5 min after the fluid challenge or at the peak MAP after administration of vasopressor.
Statistical analysis
The results are expressed as mean (SD) or as median (interquartile range [IQR]), depending on normal distribution of the Table 1 Characteristics study subjects
Characteristics
All subjects (n 562) (%) 9 The concordance of the variation of cardiac output measured by DCO and each PPCO algorithm was assessed by Bland-Altman analysis. 8 Percentage of the concordance was estimated using the percentage of data in which the direction of change was in agreement in 4-quandrant plots. Acceptable concordance was .90% in 4-quadrant plots. Analyses were repeated in the fluid challenge and vasopressor bolus subgroups. Ability of the PPCO algorithms to detect responders to the fluid challenge was also assessed and compared with DCO. Subjects were defined as a «responder» to volume expansion when fluid challenge led to an increase in stroke volume .10%. P value ,0.05 was considered statistically significant. All statistical analyses were performed using R statistical software (The 'R' Foundation for Statistical Computing, Vienna, Austria).
Results
A total of 62 subjects were included; subject characteristics are summarized in Table 1 . Concordance between DCO and each PPCO algorithm Differentiation between the responders and non-responders to fluid challenge using the Liljestrand-Zander Model 25% (33/134) of fluid challenges were responsive according to DCO with an increase in stroke volume .10%. When using X4 (Liljestrand-Zander Model) for classification of responders to fluid challenge, only 13% (17/134) were positive. In comparison with DCO, the sensibility for determining fluid challenge response by the Liljestrand-Zander model was 30% and specificity was 93%.
Discussion
We analysed the agreement between DCO and 9 noncommercial PPCO algorithms during fluid challenge and vasopressors administration. The model of Liljestrand-Zander showed the best performance, namely the lowest error rate and greater concordance with DCO value for static value and after therapeutic intervention, especially after use of vasopressors. The other 8 algorithms showed correct bias after fluid challenge compared with the DCO, but there was poor agreement after vasopressor administration. Although the PPCO seems to be a good alternative to monitoring the cardiac output during surgery, many of the commercialized algorithms had difficulties, especially during vasopressor administration. Meng and colleagues showed that an algorithm derived from the Windkessel concept accurately tracks changes in cardiac output after whole-body tilting to increase preload, whereas phenylephrine-induced change in vasomotor tone profoundly affected its ability to track changes in cardiac output. In this study, vasopressor administration could induce opposite changes in cardiac ouput measuring by DCO or PPCO. The software enhancement does not seem to improve the ability of PPCO to adequately measure cardiac output when arterial compliance is modified. Our study confirmed the poor performance of the Windkessel model after a vasopressor bolus, which is similar to findings of previously published studies in the intensive care unit or operating theatre. The concordance between cardiac ouput measured with DCO and algorithms based on pressure wave form such as the Windkessel models (X4.5), Herd model (X6) and area under the curve (X7, X8, and X9), were poor after vasopressor administration. Furthermore, the relation between cardiac output variations and vasoconstrictor administration is complex and, as recently reported; depends on the volume status of the patient. 10 11 Our results are in accordance with those studies: we observed a decrease of DCO induced by vasopressor which was mostly expected as our neurosurgical subjects were fluid non-responders in 75% of cases. 10 11 Interestingly, as recently published, 12 continuous cardiac output monitoring in the operating theatre and increase accuracy of cardiac output monitoring. 5 For the response to fluid challenge, a significant discrepancy was observed between results obtained with DCO and the Liljestrand-Zander model. Indeed, 14 of the 33 positive fluid challenges classified with the DCO were negative according to the Liljestrand-Zander model (sensitivity of 30%). Therefore, for the titration of fluid in the operating room, the Liljestrand-Zander model cannot replace DCO for classifying fluid responders and nonresponders. Furthermore, we observed that the Windkessel models and area under the curve models had small bias after fluid challenge, which confirmed the possible utility of those algorithms in commercial monitors for fluid titration.
Limitations of the study
First, we used DCO as our reference technique, which does not represent the usual gold standard method; of the effect aortic diameter changes is still a matter of debate. 15 16 Nevertheless, DCO is a less invasive beat-to-beat monitor allowing detection of rapid and transient changes in cardiac output and is frequently used in studies dealing with cardiac output variations induced by vasoactive drugs, despite these limitations. 6 17 Second, our comparison did not include the third-generation of commercial PPCO algorithms. Those algorithms could have better results for vasopressor administration than the noncommercial algorithms that we tested. Third, a small percentage of our subjects were responders to fluid challenge. Therefore, further studies are needed to confirm our results on different populations of patients. Finally we used automated data collection and only two items could be collected directly by the monitor just before the event: 'fluid infusion' and 'vasopressor bolus'. Thus, we could not compare the differential effects of phenylephrine, ephedrine and norepinephrine on cardiac output.
Conclusions
Our study showed that the Liljestrand-Zander PPCO model, after initial calibration with DCO, demonstrated the least bias and best limits of agreement, especially after vasopressor use. The combination of these two devices could then facilitate continuous cardiac output monitoring in the operating theatre. Further studies are needed to confirm our results and to better assess the usefulness of the Liljestrand-Zander model of PPCO in clinical practice.
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online.
